- Report
- August 2023
- 51 Pages
Australia
From €534EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Japan
From €534EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Turkey
From €534EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Italy
From €534EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
United Kingdom
From €534EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
China
From €534EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Switzerland
From €534EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Argentina
From €534EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Brazil
From €534EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Israel
From €534EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Colombia
From €534EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
India
From €534EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
South Africa
From €534EUR$600USD£469GBP
- Report
- June 2023
- 263 Pages
Global
From €3203EUR$3,600USD£2,812GBP
- Report
- August 2022
- 327 Pages
Global
From €3203EUR$3,600USD£2,812GBP
- Report
- September 2022
- 33 Pages
Global
From €885EUR$995USD£777GBP
- Report
- June 2023
- 62 Pages
Global
From €1735EUR$1,950USD£1,523GBP
- Report
- June 2025
- 77 Pages
Japan
From €2180EUR$2,450USD£1,913GBP
- Report
- October 2024
- 83 Pages
Global
From €4315EUR$4,850USD£3,788GBP
- Report
- September 2024
- 89 Pages
Global
From €4315EUR$4,850USD£3,788GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more